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Abstract: The cycloaddition between protonated glyoxylate imines possessing two 
chiral auxiliaries, N-(S)- or N-(R)-1-phenylethyl and (-)-8-phenylmenthyl or (+)-8-
phenylneomenthyl, and cyclopentadiene is described. The absolute configuration of all 
adducts formed was unequivocally assigned through NMR, specific optical rotation and 
X-ray data of appropriated derivatives. Experimental results confirm the highly exo-
selectivity for these aza-Diels–Alder reactions, single adducts being obtained from 
combinations of (8PM)-(R-PEA) and (8PNM)-(S-PEA). 
 
Keywords: Asymetric synthesis; Cycloadditions; Aza-Diels-Alder reaction; Induction; 
Chiral auxiliaries. 
 
 
1. Introduction 
The great versatility of cycloadditions, their high stereochemical control and the fair 
predictability of their regiochemistry allied to the rapid accumulation of 
polyfunctionality in a relatively small molecular framework, have contributed to the 
popularity of these reactions.
1 
Within the diverse transformations comprising 
cycloadditions, aza-Diels-Alder reactions of imine derivatives and dienes leading to six-
membered aza-heterocycles, monocyclic and bicyclic molecules, have attracted much 
interest, especially those employing cyclopentadiene as starting material.
2,3
 The imines, 
used as aza-dienophiles, generally require activation by an electron-withdrawing group 
and a Lewis acid (LA) and/or Bronsted acid (BA) to participate in these [4+2] 
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cycloaddition reactions.
3 
It has been shown that the electronic nature of the substituents 
at the diene/dienophile pair may strongly influence the reaction pathways and determine 
either a concerted mechanism (synchronous or asynchronous) or a stepwise one.
4 
In 
addition, experimentalists have always employed catalysts to change the kinetics of this 
class of reactions. In particular, a wide range of homogeneous and heterogeneous Lewis 
acids have been used to improve the rate and exo/endo selectivities of these 
cycloadditions.
2,3 
The products obtained, 2-azabicyclo[2.2.1]hept-5-enes,
3
 can be used as precursors of a 
large variety of compounds of chemical, biological and pharmaceutical interest.
5,6
 The 
products obtained in these reactions contain a highly functionalized bridged [2.2.1] ring 
system that may undergo further transformations (Scheme 1). Oxidation of the double 
bond, ring opening of the vicinal-diol, reduction or hydrolysis of the ester functionality 
would lead to a great number of chiral nonnatural amino alcohols and α-amino acids 
(pyrrolidine derivatives). Many of these “glycomimetics”, also called azasugars, may  
show useful activity as glycosidase inhibitors
7 
with application as antiviral,
8
 included 
potential nonnucleosidic inhibitors of HIV replication,
9
 antineoplastic
10
 and antidiabetic 
agents.
11 
On the other hand, the sequence based on Barbier-Wieland degradation and the 
cleavage of the N-C3 bond, would lead to chiral bicyclic lactams, useful as precursors of 
GABA analogs,
12
 and chiral amino alcohols, derived from cyclopentene and 
cyclopentane, useful for the synthesis of carbocyclic nucleosides with antiviral and 
antineoplastic properties.
13 
 
Scheme 1. 2-azabicyclo[2.2.1]hept-5-enes as precursors of a large variety of compounds. 
Bailey and co-workers
14
 investigated cycloadditions of (-)-8-phenylmenthyl (R)- and 
(S)-N-1-phenylethylimino glyoxylates with cyclopentadiene. The reaction showed high 
diastereoselectivity when the R-1-phenylethyl group was incorporated in the imine 
(>95%), and poor selectivitiy when the S-1-phenylethyl group was incorporated in the 
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imine (<49%). The absolute configuration of the stereoisomers obtained was not 
determined, but the stereochemistry of the single product (bicycle) obtained in the case 
of the imine with the R-1-phenylethyl group was assumed to be (3S, exo), according to 
results obtained before
 
by L. Stella and co-workers
3e
 with racemic methyl 1-
phenylethylimine glyoxylate. Obviously, the reaction outcomes cannot be compared, as 
in one case (Bailey) 8-phenylmenthyl glyoxylate and in the other case (Stella) methyl 
glyoxylate was used. In fact, and as can be confirmed further in this paper, using 8-
phenylneomenthyl glyoxylate and (R)-1-phenylethylamine (R-PEA) 3 diastereoisomers 
were obtained. 
Our reasons to re-visit these reactions were first, to confirm the sterochemistry of these 
reactions for which no conclusive evidences had been apported before; and second, to 
enlarge the scope of these cycloadditions incorporating another menthyl chiral auxiliary, 
(+)-8-phenylneomenthyl, instead of the virtually inaccessible (+)-8-phenylmenthol (~ 
500 euro/g), providing an alternative route to the obtention of the reverse adducts. 
In a previous work on cycloadditions between chiral iminodienophiles of glyoxylates of 
8-phenylmenthols and cyclopentadiene, we showed these reactions to be highly 
accelerated by the addition of a LA, due to the formation of an iminium cation complex 
that rapidly undergoes cycloaddition under mild conditions to give products with high 
stereo exo selectivity.
3c,3d,6b 
Herein we describe the most efficient synthesis of all the 
adducts formed in the cycloaddition of N-(S)- or N-(R)-1-phenylethylimines of (-)-8-
phenylmenthyl or (+)-8-phenylneomenthyl glyoxylates, and cyclopentadiene. The 
assignement of the absolute configuration of all the adducts formed was achieved 
through NMR, specific optical rotation and X-ray data of the appropriated derivatives. 
 
2. Results and discussion 
(-)-8-Phenylmenthol (1a),
15a
 and (+)-8-phenylneomenthol (1b),
15b,c
 were obtained 
before in our laboratory in good yields, from inexpensive (+)-(R)-pulegone, and are 
therfore non-expensive chiral auxiliaries. Conversion of the alcohols into the 
corresponding glyoxylates (3a and 3b) was achieved by reaction with acryloyl chloride 
in the presence of Et3N and DMAP, followed by treatment of the resulting acrylates (2a, 
2b) with either ozone (with Me2S quenching) or OsO4 and NaIO4.
3c,15d,e
 Treatment of 
the glyoxylate (3a or 3b) with equimolar amounts of 1-phenylethylamine (R-PEA or S-
PEA), trifluoroacetic acid (TFA) and BF3.OEt2 in DCM generated the corresponding 
iminium salt (protonated imine) (4), which reacted in situ with excess cyclopentadiene 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
at -78 ºC to give the corresponding adducts (5 / 6) (scheme 2). The reaction was 
monitored by TLC (aliquots treated with NaHCO3), and the total consumption of the 
imine was observed after 5 hours. 
 
Scheme 2. Synthesis of 2-azabicyclo[2.2.1]hept-5-ene derivatives via cycloadducts 5 and 6. 
Reagents and conditions: (a) acryloyl chloride, DCM, Et3N, DMAP, 0ºC; (b) 1) O3, DCM, -
78ºC; 2) SMe2; (c) OsO4, NaIO4, dioxane/H2O; (d) 1) R-PEA or S-PEA, DCM, 0ºC, 1h; 2) TFA, 
BF3.OEt2, -78ºC; (e) 1) cyclopentadiene, -78ºC, 5 h; 2) NaHCO3 /H2O; (f) 1) LiAlH4, Et2O, 12h; 
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2) H2O; (g) 3,5-dinitrobenzoyl chloride, DMAP, DCM; (h) OsO4, NMO, tert-butanol/THF/H2O; 
(i) TFA, Et2O. 
Treatment of the exo-cycloadducts 5a, 5b and the endo-cycloadduct 6a with LiAlH4
3c,d,k
 
afforded the corresponding amino alcohols 7, while allowing quantitative recovery of 
the chiral auxiliaries (1a and 1b, respectively)
16
 with retention of configuration in all 
cases. Attempts to reduce endo-cycloadduct 6b with LiAlH4 were not successful.  
The results of the aza-Diels-Alder reactions are presented in table 1. 
Table 1. The results for the aza-Diels-Alder reaction between cyclopentadiene and in situ 
generated N-phenylethyliminoacetates of (-)-8-phenylmenthol and (+)-8-phenylneomenthol (-
78ºC, 5 hours). 
Entry Glyoxylate Phenylethylamine Products-yield (%)
a
 
1 
 
 
 
2 
 
 
 
3 
 
 
 
4 
 
 
 
a
 After chromatographic purification  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
As can be seen, on reaction with cyclopentadiene (-)-8-phenylmenthyl (R)-N-
phenylethylimino glyoxylate (entry 1) gave the single product 5a1 (1S, 3exo) in 79 % 
yield; (-)-8-phenylmenthyl (S)-N-phenylethylimino glyoxylate (entry 2) gave a mixture 
of products: 5a2 (1S, 3exo), 25 % yield; 5a3 (1R, 3exo), 35 % yield; 6a (1R, 3endo), 15 
% yield; (+)-8-phenylneomenthyl (S)-N-phenylethylimino glyoxylate (entry 3) gave the 
single product 5b1 (1R, 3exo) in 76 % yield; (+)-8-phenylneomenthyl (R)-N-
phenylethylimino glyoxylate derivative (entry 4) gave a mixture of cycloadducts: 5b2 
(1R, 3exo), 26 % yield; 5b3 (1S, 3exo) in 37 % yield; 6b (1R, 3endo) in 10 % yield.  
Resuming, reactions of cyclopentadiene with 3a and (R)-PEA and with 3b and (S)-PEA 
yielded only one optically pure adduct (reverse adduct families (1S,3exo)- and 
(1R,3exo)-2-azabicyclo[2.2.1hept-5-enes, respectivelly). The other combinations of 
these two reagents (3a/(S)-PEA and 3b/(R)-PEA) led to a mixture of three 
diastereomeric adducts.  
In an attempt to explain this outcome we present in Scheme 3 a model for the approach 
of diene and dienophile. Taking into account, simultaneously, polar effects (hydrogen 
bonding) and repulsive interactions in the different conformations, the geometry 
corresponding to a syn-syn-syn alignment
3d
 is the one which best explains the obtention 
of the single adduct (1S,3exo) with the chiral auxiliaries 8-phenylmenthol/R-phenylethyl 
(attack on the si face) and the obtention of other single adduct (1R,3exo) with the chiral 
auxiliaries 8-phenylneomenthol/S-phenylethyl (attack on the re face). The high exo-
selectivity observed in these cases may be explained considering that: 
* the iminium ion, which acts as dienophile in the reaction, should have an E 
configuration, more stable for stereochemical (bulky groups far apart) and polar 
(hydrogen bonding C=O / N+-H) reasons. 
* in the close vicinity of the C=N bond, the 1-phenylethyl group exerts a larger steric 
hindrance than the ester group. 
Consequently, in order to minimize stereochemical interactions (in the transition state) 
between the methylene group of the diene and the bulky substituents of the dienophile, 
the approach diene-dienophile must occur in an exo manner. The stereochemical factors 
are more important than the secondary orbital interactions between the π systems of 
cyclopentadiene and the ester group in the dienophile. The configuration of the nitrogen 
atom in the final adduct is irrelevant, since it exists as a tertiary amine, after work up 
(HCO3
-
), capable of undergoing inversion of the lone pair of electrons to achieve the 
most stable conformation. 
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Scheme 3. Model for the approach of diene (cyclopentadiene) and iminium cations of corresponding 
imino-acetates to afford single adducts 5a1 and 5b1 
In what concerns the preference observed in the approach of the diene to the 
diastereotopic faces of the dienophile, it is more difficult to suggest a hypothesis. The 
presence of two chiral auxiliaries and in particular the stereochemistry of the 
phenylethyl group must play an important role in the obtention of the single adducts, 
since the need for coplanarity of the benzene rings and for maximum distance of bulky 
substituents turns one of the diastereotopic faces much less hindered than the other. In 
the case of R-phenylethylamine, coplanarity of the benzene ring and maximum distance 
of this substituent from the phenylmenthyl group places the methyl group of the 
phenylethylamine backwards to the re-face and favors therefore highly attack from the 
less hindered si-face. In the case of S-phenylethylamine a similar rationalizing explains 
the preference for the re-face. 
For the determination of the absolute configurations of adducts 5 and 6, the 
transformations outlined in Scheme 4 were performed. Reduction with LiAlH4 of the 
exo cycloadducts 5a,b gave the four alcohols (+)-7A, (-)-7A, (+)-7B, (-)-7B, whose 
optical rotations were determined. The absolute configuration of adduct 5a3 (1R,3exo) 
was unequivocally determined from crystallographic data of X-ray diffraction of the 
corresponding aminoalcohol (+)-7A (1R,3exo) (figure 1).
17 
Amino alcohols 7A and 7B 
were transformed into the corresponding 3,5-dinitrobenzoates (8) by reaction with 3,5-
dinitrobenzoyl chloride. The absolute configuration of adduct 5a2 (1S,3exo) was 
unequivocally determined from crystallographic data of X-ray diffraction of the 
corresponding 3,5-dinitrobenzoyl derivative (-)-8B (figure 2)
18
 prepared from the 
corresponding aminoalcohol (-)-7B (1S,3exo). The absolute configurations of the 
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remaining aducts, 5b1 (1R,3exo), 5b2 (1R,3exo) and 5b3 (1S,3exo), were determined by 
comparison of NMR spectroscopic data (
1
H and 
13
C) and specific rotation data of the 
corresponding aminoalcohol derivatives, (+)-7A, (+)-7B and (-)-7A, respectively, with 
the values obtained for their enantiomers (configuration determined by X-ray). 
Dihydroxylation of endo-cycloadduct 6a with OsO4 in the presence of N-
methylmorpholine-N-oxide yielded diol 9 as crystals suitable for X-ray analysis (figure 
3).
19
 In the case of endo-adduct 6b (1S,3endo), the absolute configuration was 
unequivocally determined from crystallographic data of X-ray diffraction of the 
corresponding ammonium trifluoroacetate 10 (1S,3endo) (figure 4).
20
 
 
a 
See Scheme 2. 
Scheme 4. Determination of the absolute configuration of adducts 5 and 6: Transformations 
performed.
a 
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Fig. 1. X-ray single crystal structures of compounds (+)-7A,
17
 (-)-8B,
18
 (-)-9
19
 and 
(+)-10.
20
 
 
3. Conclusions 
The results obtained illustrate the utility of (-)-8-phenylmenthol and (+)-8-
phenylneomenthol (used instead of virtually inaccessible (+)-8-phenylmenthol) as easily 
recoverable stereo controlling auxiliaries, affording optically pure 3-functionalized 2-
azabicyclo[2.2.1]hept-5-enes from aza-Diels-Alder reaction between cyclopentadiene 
and chiral protonated phenylethylimines, formed from the corresponding (R)- or (S)-
phenylethylamine and the glyoxylates of these alcohols. For the combination of the 
auxiliaries N-(S)-phenylethyl / 8-phenylmenthyl and N-(R)-phenylethyl / 8-
phenylneomenthyl, the reaction yielded three diastereomers, (1R,3exo)-5a3,  (1S,3exo)-
5a2, (1R,3endo)-6a (2.3:1.7:1) and (1S,3exo)-5b3,  (1S,3exo)-5b2, (1S,3endo)-6b 
(3.7:2.6:1), respectively. However, when N-(R)-phenylethyl / 8-phenylmenthyl and N-
(S)-phenylethyl / 8-phenylneomenthyl were used in combination, only a single 
diastereomeric adduct was obtained, (1S,3exo)-5a1 (79%)  and (1R,3exo)-5b1 (76%), 
respectively. We have unambiguously the absolute configuration of all the adducts 
assigned, using NMR, specific optical rotation and X-ray data of the appropriated 
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derivatives (amino alcohols 7, 3,5-dinitrobenzoates 8, diol 9  and ammonium 
trifluoroacetate 10). 
 
4. Experimental 
4.1. General Methods 
All reactions were carried out under anhydrous conditions. Solvents were dried 
according to standard procedures and distilled prior to use. All reagents were 
commercially available and used without further purification, unless otherwise stated. 
Flash column chromatography was performed on silica gel (60 Å, 230-240 mesh) and 
analytical thin-layer chromatography (TLC) on pre-coated silica gel 60 F254 plates using 
iodine vapor and/or UV light (254 nm) for visualization. Melting points were 
determined on an electrothermal melting point apparatus and are uncorrected. Infrared 
spectra were recorded on FT/IR spectrophotometers and main bands are given in cm
-1
. 
The 
1
H-NMR (300 MHz or 400 MHz) and 
13
C-NMR (75.47 MHz) spectra were 
recorded using CDCl3 as solvent and are reported in ppm downfield from TMS. Optical 
rotations were measured on a conventional thermostated polarimeter using a sodium 
lamp and are reported as follows: [α]D
t
 (c in g per 100 mL, solvent). Elementary 
analyses were obtained on a microanalyser apparatus.  
4.2. General Procedure for the synthesis of acrylates (2a,2b)3c,15d,e 
A solution of acryloyl chloride (2.10 mL, 25.8 mmol) in dry DCM (40 mL) was added 
drop wise under argon to a solution of 8-phenylmenthol (1a or 1b) (3.00 g, 12.9 mmol ), 
Et3N (3.6 mL; 26 mmol) and DMAP (227 mg, 1.81 mmol) in dry DCM (60 mL) at 0ºC. 
The mixture was stirred for 2 hours at room temperature and was then treated with 
saturated NaHCO3 solution (125 mL) and extracted with DCM (3 x 100 mL). The 
pooled organic layers were washed with saturated NaHCO3 solution (2 x 100 mL) and 
brine (100 mL), and were then dried with Na2SO4. The solvent was removed in a rotary 
evaporator, and purification of the resulting residue on a short column of silica gel using 
Et2O:EtOAc 9:1 as eluent afforded the corresponding acrylate as a yellow oil. 
4.2.1. (-)-(1R,2S,5R)-5-methyl-2-(1-methyl-1-phenylethyl)cyclohexyl acrylate 
(2a).
15e 
Yield: 97%. []D
25 
-9.5º (c1, CHCl3). 
1
H NMR (300 MHz, CDCl3):  = 0.89 (d, 3H, J 
6.6 Hz, 5’-CH3), 0.80-1.2 (m, 3H, menthyl), 1.25 (s, 3H, 8’-CH3), 1.34 (s, 3H, 8’-CH3), 
1.38-1.59 (m, 1H, menthyl), 1.60-1.74 (m, 2H, menthyl), 1.76-1.96 (m, 2H, menthyl), 
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1.97-2.35 (m, 2H, menthyl), 4.90 (dt, 1H, Jt 10.7 Hz, Jd 4.3 Hz, H1’), 5.55-5.65 (m, 2H, 
H2 + H3a), 6.02-6.11 (dd, 1H, J 13.9, 5.0 Hz, H3b), 7.10-7.14 (m, 1H, Ph), 7.23-7.30 
(m, 4H, Ph). 
13
C NMR (CDCl3):  = 22.2 (5’-CH3), 25.8 (8’-CH3), 27.0 (C4’), 28.0 (8’-
CH3), 31.7 (C5’), 35.0 (C3’), 40.1 (C8’q), 42.0 (C6’), 50.9 (C2’), 75.0 (C1’), 125.4 
(C4Ph), 126.4 (C3Ph + C5Ph), 128.4 (C2Ph + C6Ph), 129.3 (C2), 130.3 (C3), 152.0 (C1Ph), 
165.8 (C(O)O). IR (NaCl):  = 2954, 2924, 1740, 1719, 1634, 1457, 1405, 1371, 1270, 
1181, 1131, 1048, 984, 809, 700 cm
-1
. Anal.: calcd. for C19H26O2: C, 79.67; H, 9.15; 
found: C, 79.53; H, 9.41. 
4.2.2. (+)-(1S,2S,5R)-5-methyl-2-(1-methyl-1-phenylethyl)cyclohexyl acrylate (2b). 
Yield: 95%. []D
25 
+53.1º (c1, CHCl3). 
1
H NMR (300 MHz, CDCl3):  = 0.82 (d, 3H, J 
6.6 Hz, 5’-CH3), 0.85-1.10 (m, 2H, neomenthyl), 1.33 [s, 6H, 8´-(CH3)2], 1.46-1.67 (m, 
4H, neomenthyl), 1.67-1.80 (m, 1H, neomenthyl), 1.86-1.99 (m, 1H, neomenthyl), 5.15 
(br.s, 1H, H1’), 5.80 (dd, 1H, Jcis 10.4 Hz, Jgem 1.6 Hz, H3E), 6.07 (dd, 1H, Jtrans 17.3 
Hz, Jcis 10.4 Hz, H2), 6.34 (dd, 1H, Jtrans 17.3 Hz, Jgem 1.6 Hz, H3Z), 7.10-7.22 (m, 1H, 
Ph), 7.25-7.30 (m, 4H, Ph). 
13
C NMR (CDCl3):  = 22.4 (5’-CH3), 22.8 (C4’), 26.5, 
27.0 and 27.3 (8´-CH3, C5’), 35.7 (C3’), 40.2 (C6’), 40.4 (C8’q), 51.7 (C2’), 71.9 (C1’), 
126.0 (C4Ph), 126.4 (C2Ph + C6Ph), 128.4 (C3Ph + C5Ph), 129.8 (C2), 130.5 (C3), 149.9 
(C1Ph), 165.6 (C(O)O). IR (NaCl):  = 2948, 1718, 1636, 1496, 1456, 1404, 1369, 1270, 
1197, 1147, 1047, 984, 810, 760, 700 cm
-1
. Anal.: calcd. for C19H26O2: C, 79.67; H, 
9.15; found: C, 79.85; H, 9.23. 
4.3. General Procedure for the synthesis of glyoxylates (3a,3b) 3c,15d,e 
Method A. A vigorously stirred solution of acrylate (2a or 2b) (3.20 g, 11.1 mmol ) in 
140 mL of MeOH:DCM 4:1 at –78ºC was bubbled for 20 min with ozone at a rate of 
6g/h in a 60 L/h current of O2 (as specified by manufactures of the Fischer Mod. 503 
ozone apparatus). Me2S (2 mL), was added and stirring was continued under argon for a 
further 12 h, time after which the solvent was evaporated and the residue extracted with 
DCM (3 x 100 mL). The pooled organic layers were washed with water (100 mL) and 
brine (100 mL) and dried over Na2SO4. Removal of the solvent in a rotary evaporator 
afforded a yellow oil, which was purified on a short column of silica gel using 
hexane:EtOAc 3:1 as eluent yielding the corresponding glyoxylate as a mixture of the 
glyoxylate and its hydrate which was used without further purification.  
Method B. A mixture of acrylate (2a or 2b) (2.35 g, 8.205 mmol ), OsO4 (20.8 mg, 10 
meq.), water (9 mL) and dioxane (30 mL ) was stirred at rt for 5 min., time during 
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which the mixture became dark brown. Then NaIO4 (3.51 g, 2eq.) was added in portions 
over 30 min, and the mixture (now pale brown) was stirred at room temperature for 
another 2 h and then extracted thoroughly with Et2O. The combined organic extracts 
were dried (Na2SO4) and concentrated, affording a yellow oil that upon filtration 
through a short column of silica gel using hexane:EtOAc 3:1 as eluent afforded 
corresponding glyoxylate as a mixture of the glyoxylate and its hydrate which was used 
without further purification. After heating a small sample for 2 hours at 50 ºC under 
reduced pressure (10
-3
 mmHg), the 
1
H and 
13
C-NMR spectra showed it to be essentially 
(> 85%) the anhydrous form of the corresponding glyoxylate. 
4.3.1. (-)-(1R,2S,5R)-5-methyl-2-(1-methyl-1-phenylethyl)cyclohexyl glyoxylate 
(3a). 
Yield: 97% (method A). Yield: 98% (method B). 
An analytical sample of the mono-hydrate was obtained by recrystallization from 
hexane. 
(-)-(1R,2S,5R)-5-methyl-2-(1-methyl-1-phenylethyl)cyclohexyl glyoxylate hydrate. 
M.p. 146-148ºC (hexane). 
1
H NMR (300 MHz, CDCl3):  = 0.85 (d, 3H, J 6.4 Hz, 5’-
CH3), 0.97-1.18 (m, 2H, phenylmenthyl), 1.30 (s, 3H, 8’-CH3), 1.38 (s, 3H, 8’-CH3), 
1.40-1.70 (m, 5H, phenylmenthyl), 1.81-2.21 (m, 3H, phenylmenthyl + C(OH)2), 4.87 
(dt, 1H, Jt 10.7 Hz, Jd 4.4 Hz, H1’), 7.10-7.15 (m, 1H, Ph), 7.23-7.29 (m, 4H, Ph). 
13
C 
NMR (CDCl3):  = 22.1, 25.4, 28.1, 29.2, 31.7, 34.8, 40.6, 41.6 (C8’), 50.9 (C2’), 77.5 
(C1PM), 125.8 (C4Ph), 126.1 (C2Ph + C6Ph), 128.4 (C3Ph + C5Ph), 150.6 (C1Ph), 159.9 
(CH(OH)2), 162.9 [C(O)O]. IR (NaCl):  = 3464, 2955, 2924, 2870, 1732, 1497, 1389, 
1370, 1289, 1227, 1094, 980, 766, 702 cm
-1
. Anal.: calcd. for C18H26O4: C, 70.56; H, 
8.55; found: C, 70.79; H, 8.33. 
4.3.2. (+)-(1S,2S,5R)-5-methyl-2-(1-methyl-1-phenylethyl)cyclohexyl glyoxylate (3b) 
(Mixture of glyoxylate/hydrate). 
Yield: 96% (method A). Yield: 98% (method B). []D
25 
+36 (c1, CHCl3). 
1
H NMR (300 
MHz, CDCl3):  = 0.82 (d, 3H, J 6.4 Hz, 5’-CH3), 0.88-1.27 (m, 2H, 
phenylneomenthyl), 1.34 (s, 3H, 8’-CH3), 1.35 (s, 3H, 8’-CH3), 1.50-1.93 (m, 6H, 
phenylneomenthyl), 4.85-5.15 (m, 1H, H1’), 7.14-7.19 (m, 1H, Ph), 7.24-7.28 (m, 4H, 
Ph), 9.17 (s, 1H, CHO). 
13
C NMR (CDCl3):  = 22.4 (5’-CH3), 22.7 (C4’), 26.3 (C5’), 
27.1 (8´-CH3), 27.7 (8´-CH3), 35.6 (C3’), 40.3 (C6’), 40.4 (C8’), 51.6 (C2’), 74.6 (C1’), 
126.2(C4Ph), 126.37 (C2Ph + C6Ph), 128.61 (C3Ph + C5Ph), 148.78 (C1Ph), 159.19 
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(C(O)O), 184.53 (HC=O). IR (NaCl):  = 3445, 2948, 1733, 1601, 1496, 1456, 1404, 
1371, 1219, 1096, 918, 836, 760, 700 cm
-1
. Anal.: calcd. for C18H24O3: C, 74.97; H, 
8.39; found: C, 75.15; H, 8.21. 
 
Compound (3a or 3b) was converted into the corresponding 2,4-dinitrophenylhydrazone 
derivative, by the usual procedure.
21
 
A solution of 2,4-dinitrophenylhydrazine (82 mg, 0.42 mmol) and H2SO4 (0.2 mL) in 
absolute MeOH was added to a solution of the glyoxylate and its hydrate (100 mg, 
aprox. 0.3467 mmol) in the minimum quantity of MeOH, at rt. The solid obtained was 
isolated by filtration and recrystallized from absolute MeOH, yielding a yellow solid 
(0.145 g) which was identified as the corresponding 2,4-dinitrophenylhydrazone.  
2,4-Dinitrophenylhydrazone of (-)-8-phenylmenthyl glyoxylate (3a-2,4-DNP).
21 
Yield 89%. Mp. 159-162ºC (MeOH). []D
25 
-17.5º (c 1.0, CHCl3). 
1
H NMR (300 MHz, 
CDCl3):  = 0.91 (d, 3H, J 6.5 Hz, 5’-CH3), 0.95-1.17 (m, 2H, phenylmenthyl), 1.12 (s, 
3H, 8’-CH3), 1.32 (s, 3H, 8’-CH3), 1.49-1.60 (m, 2H, phenylmenthyl), 1.70-1.78 (m, 
1H, phenylmenthyl), 1.91-1.97 (m, 2H, phenylmenthyl), 2.18 (td, 1H, Jt 11.4 Hz, Jd 3.4 
Hz, phenylmenthyl), 5.03 (td, 1H, Jt 10.7 Hz, Jd 4.4 Hz, H1’), 6.07 (s, 1H, CH=N), 
7.06-7.11 (m, 1H, Ph), 7.19-7.29 (m, 4H, Ph), 8.04 (d, 1H, J 9.5 Hz, H6DNP), 8.38 (dd, 
1H, J 9.5, J = 2.6 Hz, H5DNP), 9.15 (d, 1H, J 2.6 Hz, H3DNP), 14.08 (s, 1H, NH). IR 
(KBr):  = 3272, 2965, 1687, 1618, 1596, 1570, 1423, 1336, 1310, 1215, 1139, 1085, 
1052, 920, 871, 834, 763, 742, 700 cm
-1
. Anal.: calcd. for C24H28N4O6: C, 61.53; H, 
6.02; N, 11.96; found: C, 61.46; H, 6.18; N, 12.02. 
2,4-Dinitrophenylhydrazone of (+)-8-phenylneomenthyl glyoxylate (3b-2,4-DNP).
3c 
Yield 90%. Mp. 105-108ºC (MeOH). []D
25 
+35º (c 0.5, CHCl3). 
1
H NMR (300 MHz, 
CDCl3):  = 0.84 (d, 3H, J 6.5 Hz, 5-CH3), 0.90-1.28 (m, 2H, phenylneomenthyl), 1.39 
(s, 6H, 8’-(CH3)2), 1.55-1.85 (m, 5H, phenylneomenthyl), 1.90-2.05 (m, 1H, 
phenylneomenthyl), 5.10 (br s, 1H, H1’), 6.87 (s, 1H, CH=N), 7.10-7.23 (m, 1H, Ph), 
7.26-7.30 (m, 4H, Ph), 8.12 (d, 1H, J 9.5 Hz, H6DNP), 8.44 (dd, 1H, J = 9.5, 2.6 Hz, 
H5DNP), 9.15 (d, 1H, J 2.6 Hz, H3DNP), 14.40 (s, 1H, NH). 
13
C NMR (300 MHz, 
CDCl3):  = 22.3 (5’-CH3), 22.7 (C4’), 26.5 (C5’), 27.3 (8’-CH3), 27.7 (8’-CH3), 35.6 
(C3’), 40.0 (C6’), 40.4 (C8’), 51.6 (C2’), 74.0 (C1’), 118.1 (C6DNP), 123.4 (C3DNP), 
126.0 (C4Ph), 126.3 (C2Ph + C6Ph), 126.4 (C5DNP), 128.5 (C3Ph + C5Ph), 131.6 (C2DNP), 
137.3 (C4DNP), 140.6 (C1DNP), 144.4 (CH=N), 149.3 (C1Ph), 161.8 (C(O)O). IR (KBr):  
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= 3292, 3106, 2949, 1718, 1654, 1619, 1583, 1506, 1424, 1324, 1269, 1212, 1138, 
1097, 918, 834, 758, 742, 701 cm
-1
. Anal.: calcd. for C24H28N4O6: C, 61.53; H, 6.02; N, 
11.96; found: C, 61.37; H, 6.18; N, 12.17. 
4.4. General procedure for aza-Diels-Alder reaction 
4.4.1. (-)-(1R,2S,5R)-8-phenylmenthyl (1S,3S,4R)-2-[(1R)-1-phenylethyl)]-2-
azabicyclo[2.2.1]hept-5-ene-3-carboxylate (5a1).
6 
A solution of (R)-1-phenylethylamine (1.86 mL, 1.70 g, 14.0 mmol) in dry DCM (10 
mL) was added drop wise under argon to a stirred suspension of (-)-8-phenylmenthyl 
glyoxylate (3a) (4.04 g, ca. 14.0 mmol) and 3Å molecular sieves (10 g) in dry DCM (50 
mL) at 0ºC. The reaction mixture was stirred for 1 hour and then cooled to –78ºC and 
treated successively with TFA 1.08 mL, 1.60 g, 14.0 mmol), BF3.OEt2 (1.77 mL, 1.99 g, 
14.0 mmol) and freshly distilled cyclopentadiene (2.3 mL, ca. 28 mmol). After 5 h a 
mixture of saturated aqueous NaHCO3 solution (28 mL) and then solid NaHCO3 (3.3 g) 
were added. The reaction mixture was allowed to reach room temperature and filtered 
through a pad of celite. The two layers were separated and the aqueous layer was 
extracted with DCM (3 x 100 mL). The aqueous layer was extracted with DCM (3 x 
100 mL). The pooled organic layers were washed with saturated NaHCO3 solution (3 x 
100 mL) and brine (100 mL) and dried (Na2SO4). Removal of the solvent on a rotavap 
yielded an orange oil which was purified by column chromatography (silica gel) using 
hexane:AcOEt 3:1 as eluent. Fractions 7-10 (Rf  0.6.) afforded a colorless oil (5.09 g) 
identified as the pure single adduct (1R, 3exo) (5a1). Yield 79%. []D
25
 -66.5º (c 1, 
CHCl3). 
1
H NMR (300 MHz, CDCl3): δ = 0.67 (s, 3H, 8’-CH3), 0.65-0.90 (m, 3H, H3’a 
+ H6’a + H4’a ), 0.81 (d,  3H, J 6.3 Hz, 5’-CH3), 0.89 (s, 3H, 8’-CH3), 1.11-1.27 (m, 1H, 
H3’b), 1.37 (d, 3H, J 6.5 Hz, CHCH3Ph), 1.28-1.37 (m, 2H, H7anti + H5’), 1.38-1.51 (m, 
1H, H4’b), 1.70-1.79 (m, 1H, H2’), 1.80-1.93 (m, 2H, H7syn + H6’b), 1.99 (s, 1H, 
H3endo), 2.80 (br s, 1H, H4), 3.03 (q, 1H, J 6.5 Hz, CHCH3Ph), 4.29 (br s, 1H, H1), 4.50 
(dt, 1H, J 10.6 Hz, 4.2 Hz, H1’), 6.28 (dd, 1H, J 5.6 Hz, 1.4 Hz, H6), 6.35 (dd, 1H, J 5.6 
Hz, 2.9 Hz, H5), 7.00 (d, 2H, J 7.4 Hz, H2Ph + H6Ph), 7.01-7.38 (m, 6H, Ph), 7.37 (d, 
2H, J 7.2 Hz, H2PhCH + H6PhCH). 
13
C NMR (CDCl3): δ = 22.2 (5’-CH3), 23.8 
(CH3CHPh), 24.8 (8’-CH3), 27.3 (C3’), 28.4 (8’-CH3), 31.5 (C5’), 35.0 (C4’), 40.1 
(C8’), 41.6 (C6’), 45.7 (C7), 49.9 (C4), 50.9 (C2’), 63.6 (CHPh), 64.4 (C1), 65.6 (C3), 
75.1 (C1’), 125.2, 125.8, 127.5, 128.1, 128.3 and 128.7 (CHPh), 133.9 (C6), 136.4 (C5), 
145.4 (C1Ph-C8’), 151.9 (C1Ph-CH), 172.9 [C(O)O]. IR (NaCl): 3086, 3059, 2954, 2870, 
1741 (CO), 1600, 1564, 1494, 1454, 1371, 1347, 1325, 1289, 1244, 1219, 1191, 1169, 
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1108, 1078, 1059, 1032, 1009, 982 cm
-1
. Anal. calcd. for C31H39NO2: C 81.36, H 8.59, 
N 3.06; found: C 81.15, H 8.62, N 2.99. 
4.4.2. (+)-(1S,2S,5R)-8-phenylmenthyl (1R,3R,4S)-2-[(1S)-1-phenylethyl)]-2-
azabicyclo[2.2.1]hept-5-ene-3-carboxylate (5b1). 
Following the same procedure procedure as above, using (S)-1-phenylethylamine (1.88 
g, 15.5 mmol) and (+)-8-phenylneomenthyl glyoxylate (3b) (4.47 g, ca. 15.5 mmol). 
Flash cromatography of the crude product (Hexane:EtOAc 1:1) afforded a colourless oil 
(5.39 g) identified as pure single adduct (1S, 3exo) (5b1). Yield 76%; Rf   0.7. []D
23
 
+53.2º (c 1, CHCl3). 
1
H NMR (400 MHz, CDCl3): δ = 0.77 (s, 3H, 8’-CH3), 0.80 (d, 3H, 
J = 6.5 Hz, 5’-CH3), 0.90 (s, 3H, 8’-CH3),  0.70-0.98 (m, 2H, H4’a + H6’a), 1.13-1.19 
(m, 1H, H5’), 1.42 [d, 3H, J 6.5 Hz, CHCH3Ph)],  1.25-1.49 (m, 3H, H7anti + H2’ + 
H4’b), 1.50-1.71 (m, 2H, H3’), 1.75-1.86 (m, 1H, H6’b), 2.0 (d, 1H, J 8.4 Hz, H7syn), 
2.34 (br s, 1H, H3endo), 2.93 (br s, 1H, H4), 3.10 (q, J 6.5 Hz, 1H, CHCH3Ph), 4.36 (br s, 
1H, H1), 4.98 (br s, 1H, H1’), 6.35 (dd, 1H, J = 5.6, 1.7 Hz, H5), 6.47-6.51 (m, 1H, 
H6), 7.12-7.41 (m, 10H, Ph). 
13
C NMR (CDCl3): δ = 22.0 (C4’), 22.1 (5’-CH3), 23.2 
(C5’), 23.9 (CH3CHPh), 27.0 (8’-CH3), 27.1 (8’-CH3), 35.3 (C3’), 39.6 (two, C8’ + 
C6’), 45.4 (C7), 49.6 (C4), 50.9 (C2’), 63.1 (C1), 64.1 (CHPh), 65.5 (C3), 70.7 (C1’), 
125.3, 126.0, 127.2, 127.8 (double) and 128.4 (CHPh), 133.6 (C6), 135.9 (C5), 145.0 
(C1Ph-C8’), 150.5 (C1Ph-CH), 172.5 [C(O)O]. IR (NaCl): 2949, 1737 (CO), 1493, 1450, 
1379, 1323, 1245, 1219, 1191, 1168, 1148, 1109, 10,79, 1061, 1033, 1009, 918, 833 
cm
-1
. Anal. calcd. for C31H39NO2: C 81.36, H 8.59, N 3.06; found: C 81.18, H 8.61, N 
3.04. 
4.4.3. (-)-(1R,2S,5R)-8-phenylmenthyl (1S,3S,4R)-2-[(1S)-1-phenylethyl)]-2-
azabicyclo[2.2.1]hept-5-ene-3-carboxylate (5a2), (+)-(1R,2S,5R)-8-phenylmenthyl 
(1R,3R,4S)-2-[(1S)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-ene-3-carboxylate 
(5a3) and (-)-(1R,2S,5R)-8-phenylmenthyl (1R,3S,4S)-2-[(1S)-1-phenylethyl)]-2-
azabicyclo[2.2.1]hept-5-ene-3-carboxylate (6a). 
Following the same procedure as above, using (S)-1-phenylethylamine (3.65 g, 30.1 
mmol) and (-)-8-phenylmenthyl glyoxylate (3a) (8.69 g, ca. 30.1 mmol). Flash 
cromatography of the crude product (Hexane:EtOAc 10:1) afforded three pure 
compounds (75% global).  
(1S,3exo) (5a2): Rf  0.6; 3.44 g (25%). []D
25
 – 100.7º (c 1, CHCl3). 
1
H NMR (300 
MHz, CDCl3):  = 0.88 (d, 3H, J 6.4 Hz, 5’-CH3), 0.83-0.93 (m, 1H, H3’a), 0.94-1.12 
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(m, 2H, H6’a + H4’a), 1.13 (d, 1H, J 8.4 Hz, H7anti), 1.23 (d, 3H, J 6.5 Hz, CHCH3Ph), 
1.26 (s, 3H, 8’-CH3), 1.38 (s, 3H, 8’-CH3), 1.45-1.70 (m, 3H, + H3’b +H4’b + H5’), 1.61 
(d, 1H, J 8.4 Hz, H7syn), 2.01 (s, 1H, H3endo), 1.90-2.15 (m, 2H, H2’ + H6’b), 2.86 (s, 
1H, H4), 2.95 (q, 1H, J  6.5 Hz, CHCH3Ph), 3.48 (d, 1H, J 1.3 Hz, H1), 4.85 (dt, 1H, J 
10.6 Hz, 4.3 Hz, H1’), 5.98 (dd, 1H, J 5.54, 1.82 Hz, H6), 6.28 (dd, 1H, J 5.54, 2.31 Hz, 
H5), 7.17-7.41 (m, 10H, Ph). 
13
C NMR (CDCl3):  = 22.3 (5’-CH3), 24.6 (CH3CHPh), 
26.9 (8’-CH3), 27.29 (C4’), 27.31 (8’-CH3), 31.7 (C5’), 35.1 (C3’), 40.4 (C8’), 41.95 
(C6’), 46.2 (C7), 49.7 (C4), 50.7 (C2’), 63.7 (CHPh), 64.0 (C1), 64.9 (C3), 75.4 (C1’), 
125.6, 125.9, 127.4, 128.1, 128.4 and 128.7 (CHPh), 134.1 (C6), 136.2 (C5), 145.6 
(C1Ph-C8’), 152.0 (C1Ph-CH), 173.7 [C(O)O]. IR (NaCl):  = 3059, 2954, 1742, 1600, 
1495, 1454, 1371, 1323, 1285, 1243, 1171, 1109, 1094, 1052, 1007, 918, 839, 765, 730, 
700 cm
-1
. Anal. calcd. for C31H39NO2: C 81.36, H 8.59, N 3.06; found: C 81.27, H 8.65, 
N 3.09. 
(1R,3exo) (5a3): Rf  0.25; 4.82 g (35%). []D
25
 + 85.3º (c 1, CHCl3). 
1
H NMR (300 
MHz, CDCl3):  = 0.55-0.75 (m, 1H, H3’a), 0.78 (d, 3H, J 6.2 Hz, 5’-CH3), 0.81-0.99 
(m, 2H, H4’a + H6’a), 1.14 (s, 3H, 8’-CH3), 1.25 (s, 3H, 8’-CH3), 1.35 (d, 3H, J 6.5 Hz, 
CHCH3Ph), 1.20-1.44 (m, 4H, H4’b + H7syn + H5’ + H3’b), 1.45-1.55 (m, 1H, H2’), 
1.65-1.80 (m, 1H, H6’b), 1.82 (s, 1H, H3endo), 2.12 (d, 1H, J 8.3 Hz, H7syn), 2.69 (s, 1H, 
H4), 2.91 (q, 1H, J  6.5 Hz, CH(CH3)Ph), 4.25 (br s, 1H, H1), 4.47 dt, 1H, J 10.6 Hz, 
4.1 Hz, H1’), 6.23 (dd, 1H, J 5.5, 1.5 Hz, H6), 6.32 (dd, 1H, J 5.6, 2.9 Hz, H5), 7.12-
7.29 (m, 10H, Ph). 
13
C NMR (CDCl3):  = 22.1 (5’-CH3), 23.0 (CH3CHPh), 26.6 (8’-
CH3), 27.2 (C4’), 27.9 (8’-CH3), 31.4 (C3’), 34.9 (C5’), 40.3 (C8’), 41.40 (C6’), 45.53 
(C7), 48.7 (C4), 50.0 (C2’), 63.0 (CH3CHPh), 64.3 (C1), 65.2 (C3), 75.3 (C1’), 125.4, 
125.9, 127.5, 128.3, 128.4 and 128.7 (CHPh), 133.6 (C6), 136.6 (C5), 145.6 (C1Ph-C8’), 
151.8 (C1Ph-CH), 173.8 [C(O)O]. IR (NaCl):  = 3058, 2955, 1739, 1600, 1493, 1453, 
1371, 1323, 1290, 1247, 1167, 1107, 1055, 1031, 1009, 917, 838, 763, 699 cm
-1
. Anal. 
calcd. for C31H39NO2: C 81.36, H 8.59, N 3.06; found: C 81.29, H 8.64, N 3.10. 
(1R,3endo) (6a): Rf  0.4; 2.07 g (15%). []D
25
 – 50.5º (c 1, CHCl3). 
1
H NMR (300 MHz, 
CDCl3):  = 0.87 (d, 3H, J 6.5 Hz, 5’-CH3), 0.75-0.99 (m, 3H, H3’a + H3’a + H4’a), 
1.00-1.26 (m, 1H, H6’a), 1.23 (s, 3H, 8’-CH3), 1,28 (d, 1H, J 8.3 Hz, H7anti), 1.34 (d, 
3H, J 6.5 Hz, CHCH3Ph), 1.35 (s, 3H, 8’-CH3), 1.54 (d, 1H, J 8.3 Hz, H7syn), 1.51-1.52 
(m, 2H, H4’b + H5’), 1.88-1.99 (m, 1H, H2’), 2.05-2.13 (m, 1H, H6’b), 2.90 (br.s, 1H, 
H4), 3.36-3.52 (m, 3H, H3exo + H1 + CHCH3Ph), 4.70 (dt, 1H, Jt 10.54 Hz, Jd 4.2 Hz, 
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H1’), 5.96 (dd, 1H, J 5.52, 2.58 Hz, H5), 6.28 (dd, 1H, J 5.52, 2.91 Hz, H6), 7.17-7.42 
(m, 10H, Ph). 
13
C NMR (CDCl3):  = 22.3 (5’-CH3), 24.9 (CHCH3Ph), 25.7 (8’-CH3), 
27.0 (C4’), 28.3 (8’-CH3), 31.6 (C5’), 35.1 (C3’), 40.1 (C8’), 41.9 (C6’), 44.70 (C7), 
48.4 (C4), 50.8 (C2’), 64.1 (CHPh), 64.8 (C1), 65.2 (C3), 75.0 (C1’), 125.3, 125.8, 
127.3, 127.9, 128.4 and 128.8 (CHPh), 134.9 (C5), 139.2 (C6), 146.7 (C1Ph-C8’), 152.60 
(C1Ph-CH), 172.78 [C(O)O]. IR (NaCl):  = 3059, 2953, 1734, 1600, 1495, 1455, 1370, 
1323, 1244, 1172, 1094, 1052, 1007, 910, 839, 765, 730, 700 cm
-1
. Anal. calcd. for 
C31H39NO2: C 81.36, H 8.59, N 3.06; found: C 81.40, H 8.63, N 3.11. 
4.4.4. (+)-(1S,2S,5R)-8-phenylneomenthyl (1R,3R,4S)-2-[(1R)-1-phenylethyl)]-2-
azabicyclo[2.2.1]hept-5-ene-3-carboxylate (5b2), (-)-(1S,2S,5R)-8-
phenylneomenthyl (1S,3S,4R)-2-[(1R)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-
ene-3-carboxylate (5b3) and (+)-(1S,2S,5R)-8-phenylneomenthyl (1S,3R,4R)-2-
[(1R)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-ene-3-carboxylate (6b). 
Following the same procedure as above, using (R)-1-phenylethylamine (3.67 g, 30.3 
mmol) and  (-)-8-phenylneomenthyl glyoxylate (3b) (8.74 g, ca. 30.3 mmol). Flash 
cromatography of the crude product (Hexane:EtOAc 8:1) afforded three pure 
compounds (73% global). 
(1R,3exo) (5b2): Rf  0.5; 3.60 g (26%). []D
23
 +35.2º (c 1, CHCl3). 
1
H NMR (400 MHz, 
CDCl3): δ = 0.89 (d, 3H, J 6.4 Hz, 5’-CH3), 0.85-0.99 (m, 1H, H3’a), 1.00-1.15 (m, 1H, 
H6’a), 1.25 (d, 1H, J 8.0 Hz, H7anti), 1.29 (d, 3H, 6.4 Hz, CHCH3Ph), 1.38 (s, 3H, 8’-
CH3), 1.39 (s, 3H, 8’-CH3), 1.27-1.43 (m, 1H, H5’), 1.48-1.58 (m, 1H, H4’a), 1.59-1.87 
(m, 3H, H2’ + H4’b + H3’b), 1.90 (d, 1H, J 8.0 Hz, H7syn), 1.92-2.05 (m, 1H, H6’b), 2.48 
(br s, 1H, H3endo), 3.10 (q, 1H, J 6.4 Hz, CH(CH3)Ph), 3.13 (br s, 1H, H4), 3.57 br (s, 
1H, H1), 5.13 (br s, 1H, H1’), 6.07 (dd, 1H, J 5.6 Hz, 2.0 Hz, H5), 6.46 (dd, 1H, J 4.4, 
3.2 Hz, H6), 7.18-7.40 (m, 10H, Ph). 
13
C NMR (CDCl3): δ = 22.1 (5’-CH3), 22.5 (C4’), 
24.3 (CH3CHPh), 26.2 (8’-CH3), 26.3 (8’-CH3), 27.0 (C5’), 35.4 (C3’), 39.9 (C6’), 40.0 
(C8’), 45.9 (C7), 49.3 (C4), 51.2 (C2’), 63.4 (C1), 63.5 (CHPh), 65.0 (C3), 71.7 (C1’), 
125.6, 125.9, 127.0, 127.5, 128.0 and 128.3 (CHPh), 133.8 (C6), 135.9 (C5), 145.3 
(C1Ph-C8’), 149.8 (C1Ph-CH), 173.6 [C(O)O]. IR (NaCl): 2924, 2869, 1738, 1716, 1662, 
1600, 1449, 1370, 1276, 1245, 1218, 1169, 1147, 1109, 1080, 10,32, 1005, 973, 919, 
809 cm
-1
. Anal. calcd. for C31H39NO2: C 81.36, H 8.59, N 3.06; found: C 81.42, H 8.66, 
N 3.10. 
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(1S,3exo) (5b3): Rf  0.3; 5.13 g (37%). []D
23
 -15.6º (c 1, CHCl3). 
1
H NMR (400 MHz, 
CDCl3): δ = 0.66 (d, 3H, J = 5.6 Hz, 5’-CH3), 0.67-0.71 (m, 1H, H3’a), 0.71-0.77 (m, 
1H, H6’a), 1.27 (s, 6H, 8’-CH3), 1.29 (s, 6H, 8’-CH3), 1.22-1.35 (m, 3H, H4’a + H5’ + 
H6’b), 1.41 (d, 3H, 6.4 Hz, CHCH3Ph), 1.36-1.48 (m, 3H, H7anti + H2’ + H4’b), 1.49-
1.57 (m, 1H, H3’b), 2.12 (d, 1H, J 8.4 Hz, H7syn), 2.28 (br s, 1H, H3endo), 3.06 (q, 1H, J 
6.4 Hz, CHCH3Ph), 3.09 (br s, 1H, H4), 4.35 (br s, 1H, H1), 4.86 (br s, 1H, H1’), 6.35 
(dd, 1H, J 5.6 Hz, 1.6 Hz, H6), 6.45-6.51 (m, 1H, H5), 7.14-7.35 (m, 10H, Ph). 
13
C 
NMR (CDCl3): δ = 22.0 (C4’), 22.3 (5’-CH3), 22.9 (CH3CHPh), 25.7 (8’-CH3), 26.0 
(C5’), 26.5 (8’-CH3), 35.2 (C3’), 39.4 (C6’), 39.9 (C8’), 45.0 (C7), 48.6 (C4), 51.0 
(C2’), 62.7 (C1), 64.0 (CHPh), 65.0 (C3), 71.3 (C1’), 125.5, 125.8, 127.1, 127.8, 127.93 
and 127.94 (CHPh), 133.6 (C6), 135.8 (C5), 144.9 (C1Ph-C8’), 149.9 (C1Ph-CH), 172.9 
[C(O)O]. IR (NaCl): 2948, 1737, 1601, 1494, 1453, 1368, 1324, 1246, 1222, 1190, 
1166, 1146, 1108, 1078, 1057, 1032, 1006, 964, 922, 853, 830, 810, 757cm
-1
. Anal. 
calcd. for C31H39NO2: C 81.36, H 8.59, N 3.06; found: C 81.32, H 8.51, N 3.12. 
(1S,3endo) (6b): Rf  0.4; 1.39 g (10%). []D
23
 +45.1º (c 1, CHCl3). 
1
H NMR (400 MHz, 
CDCl3): δ = 0.85 (d, 3H, J 6.6 Hz, 5’-CH3), 0.88-0.94 (m, 1H, H3’a), 0.95-1.05 (m, 1H, 
H6’a), 1.39 (s, 3H, 8’-CH3), 1.40 (s, 3H, 8’-CH3), 1.42 (d, 3H, J 6.7 Hz, CHCH3Ph), 
1.43-1.47 (m, 1H, H7anti), 1.53-1.65 (m, 3H, H4’a + H2’ + H5’), 1.67-1.77 (m, 1H, 
H4’b), 1.73-1.81 (m, 2H, H3’b + H7syn), 1.92-2.01 (m, 1H, H6’b), 3.46 (br s, 2H, H4 + 
H3exo), 3.56 (br s, 1H, H1), 3.60 (q, 1H, J 6.7 Hz, CHCH3Ph), 4.93 (br s, 1H, H1’), 6.08 
(d, 1H, J 5.3 Hz, H5), 6.42 (dd, 1H, J 5.6 Hz, 3.0 Hz, H6), 7.17-7.45 (m, 10H, Ph).  
13
C 
NMR (CDCl3):  = 22.1 (5’-CH3), 22.6 (C4’), 24.7 (CH3CHPh), 26.2 (8’-CH3), 26.6 
(8’-CH3), 27.1 (C5’), 35.3 (C3’), 39.6 (C6’), 40.0 (C8’), 44.6 (C7), 48.4 (C4), 51.1 
(C2’), 64.2 (C3), 64.5 (C1), 64.8 (CHPh), 71.7 (C1’), 125.5, 125.6, 126.0, 126.2, 126.9, 
127.4, 127.9, 128.0, 128.2 and 128.4 (CHPh), 134.5 (C5), 139.2 (C6), 146.2 (C1Ph-C8’), 
149.7 (C1Ph-CH), 172.4 [C(O)O]. IR (NaCl): 2926, 1738, 1658, 1599, 1578, 1494, 1447, 
1370, 1317, 1276, 1175, 1148, 1115, 1073, 1029, 1000, 941, 919, 810, 762 cm
-1
. Anal. 
calcd. for C31H39NO2: C 81.36, H 8.59, N 3.06; found: C 81.42, H 8.64, N 3.13. 
4.4.5. (+)-(1S,3R,4R)-2-[(1R)-1-phenylethyl)]-3-[(1S,2S,5R)-8-phenylneomenthyl-
oxycarbonyl]-2-azabicyclo[2.2.1]hept-5-ene-2-ammonium trifluoroacetate (10). 
Compound 6b was converted into the corresponding ammonium trifluoracetate 
derivative (10), by the usual procedure: A 1 M solution of TFA in dry Et2O (200 µL, 
0.20 mmol) was added to a solution of amine 6b (100 mg, 0.19 mmol) in dry Et2O (10 
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mL), at ambient temperature. Upon slow evaporation of the solvent a white crystalline 
solid precipitated. The solid was isolated by filtration (931 mg, 85%) and identified as 
the corresponding ammonium trifluoroacetate (10). Suitable crystals of (+)-10 were 
obtained and the structure was confirmed by X-ray crystallographic analysis.
20 
M.p. 91-
93ºC. []D
23
 +10.2º (c 1, DMSO). 
1
H NMR (400 MHz, DMSO-d6): δ = 0.84 (d, 3H, J 
6.5 Hz, 5’-CH3), 0.83-0.89 (m, 1H, H4’a), 0.90-1.01 (m, 1H, H3’a), 1.02-1.10 (m, 1H, 
H6’a), 1.28 (s, 3H, 8’-CH3), 1.30 (s, 3H, 8’-CH3), 1.50-1.70 (m, 6H, H4’b + H6’b + H5’ 
+ CH3CHPh), 1.71-1.83 (m, 3H, H7anti + H3’b + H2’), 2.29 (br.s, 1H, H7syn), 3.75 (br.s, 
1H, H4), 4.09 (br.s, 1H, H1), 4.61 (br.s, 1H, H1’), 4.75 (br.s, 1H, CH3CHPh), 5.08 (br.s, 
1H, H3exo), 6.40 (br.s, 1H, H5), 6.43 (br.s, 1H, H6), 7.15-7.70 (m, 10H, Ph), 9.36 (br.s, 
1H, NH). 
13
C NMR (DMSO-d6):  = 18.3 (CH3CHPh), 21.7 (C4’), 21.8 (5’-CH3), 24.7 
(8’-CH3), 26.7 (C5’), 27.8 (8’-CH3), 34.4 (C3’), 38.7 (C6’), 38.79-40.15 (DMSO, C8’), 
45.0 (C7), 47.2 (C4), 49.4 (C2’), 65.7 (CHPh), 66.2 (C3), 69.9 (C1), 74.5 (C1’), 125.4 
(CF3COO), 125.66, 125.73, 125.80, 126.54, 126.68, 128.06, 128.42, 128.46, 128.74 and 
129.07 (CHPh), 135.5 (C1Ph-C8’), 136.2 (C6), 139.7 (C5), 136.2 (C6), 149.6 (C1Ph-CH), 
169.6 [C(O)O], 184.4 [CF3C(O)O]. 
4.5. General procedure for reduction of cycloadducts 
4.5.1. (-)-(1S,3S,4R)-2-[(1R)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-en-3-
yl]methanol [(-)-7A] from 5a1.
6 
A solution of 5a1 (1.70 g; 3.71 mmol) in dry Et2O (10 mL) was added dropwise under 
argon to a suspension of LiAlH4 (ca. 6 equiv; 0.85 g; 22.3 mmol) in dry Et2O (10 mL) 
at 0ºC. The reaction mixture was stirred for 12 h at rt rt, and then MeOH (20 mL) and 
H2O (100 mL) were added dropwise at 0ºC. The resulting mixture was extracted with 
AcOEt (4 x 100 mL) and the pooled organic layers were washed with brine (100 mL) 
and dried with Na2SO4. Removal of the solvent in a rotary evaporator left a yellow oil 
that when chromatographed on silica gel with hexane:EtOAc 3:1 as eluent afforded the 
chiral auxiliary, (-)-8-phenylmenthol (Rf 0.4; 0.84 g; 97%),
16 
in the early fractions and 
compound 7A (Rf  0.1; 0.82 g; 96%), as white solid, in the latter ones. Mp 110-113ºC 
(hexane/Et2O). []D
25
 -41.81 (c 1, CHCl3). 
1
H NMR (300 MHz, CDCl3): 1.35 (d, 1H, J 
8.5 Hz, H7anti), 1.39 (d, 3H, J 6.5 Hz, CH3CH), 1.80 (d, 1H, J 8.5 Hz, H7syn), 1.74-1.82 
(br.s, 1H, H3endo), 2.70-2.77 (m, 2H, CHHOH + H4), 3.05 (q, 1H, J 6.5 Hz, CHMe), 
2.99-3.08 (m, 1H, CHHOH), 4.15 (d, 1H, J 1.4 Hz, H1), 4.73 (br.s, 1H, D2O exch., 
OH), 6.20 (dd, J 5.6 Hz, 1.7 Hz, 1H, H6), 6.46 (m, 1H, H5), 7.19-7.31 (m, 5H, Ph). 
13
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NMR (CDCl3): 22.5 (CHMe), 45.3 (C7), 47.5 (C4), 63.3 (C1), 63.9 (CHMe), 64.3 (C3), 
65.3 (CH2OH), 127.8, 128.2 and 128.8 (CHPh), 132.1 (C6), 138.1 (C5), 146.2 (C1Ph-CH). 
IR (KBr): 3272, 3214 (OH), 2988, 2863, 1454, 1375, 1323, 1181, 1034, 1011, 806 cm
-1
. 
Anal. calcd. for C15H19NO: C 78.56, H 8.35, N 6.11; found: C 78.49, H 8.41, N 6.02. 
4.5.2. (+)-(1R,3R,4S)-2-[(1S)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-en-3-
yl]methanol [(+)-7A] from 5a3. 
Following the same procedure as above, using adduct 5a3 (2.05 g, 4.48 mmol). Flash 
cromatography of the crude product (Hexane:EtOAc 3:1) afforded the auxiliary,  (-)-8-
phenylmenthol (Rf 0.4; 1.02 g; 98%),
16 
in the early fractions and compound (+)-7A (Rf  
0.1; 0.98 g; 95%), as white solid, in the latter ones. Mp 110-113ºC (hexane/Et2O). 
[]D
25
 +41.80 (c 1, CHCl3). The NMR (
1
H, 
13
C) spectra are identical to those of 
compound (-)-7A. Anal. calcd. for C15H19NO: C 78.56, H 8.35, N 6.11; found: C 78.51, 
H 8.39, N 6.05. Suitable crystals of (+)-(1R,3exo)-7A were obtained from hexane/Et2O 
and the structure was confirmed by the X-ray crystallographic analysis.
17,6b 
4.5.3.  (+)-(1R,3R,4S)-2-[(1S)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-en-3-
yl]methanol [(+)-7A] from 5b1. 
Following the same procedure as above, using adduct 5b1 (2.00 g, 4.37 mmol). Flash 
cromatography of the crude product (Hexane:EtOAc 3:1) afforded the auxiliary, (+)-8-
phenylneomenthol (Rf 0.6; 0.99 g; 98%),
16 
in the early fractions and compound (+)-7A 
(Rf  0.1; 0.96 g; 96%), as white solid, in the latter ones. Mp 110-113ºC (hexane/Et2O). 
[]D
25
 +41.82 (c 1, CHCl3). The NMR (
1
H, 
13
C) spectra are identical to those of 
compound (-)-7A. Anal. calcd. for C15H19NO: C 78.56, H 8.35, N 6.11; found: C 78.50, 
H 8.38, N 6.07. 
4.5.4. (-)-(1S,3S,4R)-2-[(1R)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-en-3-
yl]methanol [(-)-7A] from 5b3. 
Following the same procedure as above, using adduct 5b3 (1.02 g, 2.23 mmol). Flash 
cromatography of the crude product (Hexane:EtOAc 3:1) afforded the auxiliary, (+)-8-
phenylneomenthol (Rf 0.6; 0.49 g; 95%),
16 
in the early fractions and compound    (-)-7A 
(Rf  0.1; 0.49 g; 96%), as white solid, in the later fractions. Mp 110-113ºC 
(hexane/Et2O). []D
25
 -41.81 (c 1, CHCl3). The NMR (
1
H, 
13
C) spectra are identical to 
those of compound (-)-7A. Anal. calcd. for C15H19NO: C 78.56, H 8.35, N 6.11; found: 
C 78.52 H 8.37, N 6.09. 
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4.5.5. (-)-(1S,3S,4R)-2-[(1S)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-en-3-
yl]methanol [(-)-7B] from 5a2. 
Following the same procedure as above, using adduct 5a2 (2.40 g, 5.24 mmol). Flash 
cromatography of the crude product (Hexane:EtOAc 3:1) afforded the auxiliary,  (-)-8-
phenylmenthol (Rf 0.4; 1.16 g; 95%),
16 
in the early fractions and compound (-)-7B (Rf  
0.1; 1.13 g; 94%), as yelow oil, in the latter ones. []D
25
 -97.50 (c 1, CHCl3). 
1
H NMR 
(300 MHz, CDCl3):  = 1.22 (d, 1H, J 8.5 Hz, H7anti), 1.28 (d, 3H, J 6.5 Hz, CH3), 1.76 
(d, 1H, J 8.5 Hz, H7syn), 2.04-2.07 (m, 1H, H3endo), 2.88 (br.s, 1H, H4), 2.80-2.90 (br.s, 
1H, D2O exch., OH), 3.14 (q, 1H, J 6.5 Hz, CHCH3), 3.44 (d, 1H, J 1.2 Hz, H1), 3.69 
(dd, 1H, J 10.6, 7.2 Hz, CHHOH), 3.78 (dd, 1H, J 10.6, 3.2 Hz, CHHOH), 6.04 (dd, 1H, 
J 5.6, 1.9 Hz, H6), 6.42 (m, 1H, H5), 7.22-7.36 (m, 5H, Ph). 
13
C NMR (CDCl3):  = 
24.6 (CH3), 45.6 (C7), 48.8 (C4), 62.7 (C1), 63.7 (CHCH3), 64.0 (C3), 66.2 (CH2OH), 
127.5, 127.7 and 128.9 (CHPh), 133.5 (C6), 138.1 (C5), 145.1 (C1Ph-CH). IR (NaCl):  = 
3382, 3060, 2971, 2873, 1659, 1601, 1493, 1453, 1371, 1324, 1283, 1246, 1210, 1187, 
1080, 1020, 912, 893, 831, 762, 702 cm
-1
. Anal. calcd. for C15H19NO: C 78.56, H 8.35, 
N 6.11; found: C 78.51 H 8.39, N 6.13. 
4.5.6. (+)-(1R,3R,4S)-2-[(1R)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-en-3-
yl]methanol [(+)-7B] from 5b2. 
Following the same procedure as above, using adduct 5b2 (1.07 g, 2.34 mmol). Flash 
cromatography of the crude product (Hexane:EtOAc 3:1) afforded the auxiliary, (+)-8-
phenylneomenthol (Rf 0.6; 0.52 g; 95%),
16 
in the early fractions and compound (+)-7B 
(Rf  0.1; 0.52 g; 96%), as yelow oil, in the latter ones. []D
25
 -97.51 (c 1, CHCl3). The 
NMR (
1
H, 
13
C) spectra are identical to those of compound (-)-7B. Anal. calcd. for 
C15H19NO: C 78.56, H 8.35, N 6.11; found: C 78.52 H 8.38, N 6.12. 
4.5.7. (-)-(1R,3S,4S)-2-[(1S)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-en-3-
yl]methanol [(-)-7C] from endo-6a. 
Following the same procedure as above, using adduct 6a (2.02 g, 4.41 mmol). Flash 
cromatography of the crude product (Hexane:EtOAc 3:1) afforded the auxiliary,  (-)-8-
phenylmenthol (Rf 0.4; 0.97 g; 95%),
16 
in the early fractions and compound (-)-7C (Rf  
0.1; 0.93 g; 92%), as yelow oil, in the later fractions. []D
25
 -46.16 (c 1, CHCl3). 
1
H 
NMR (300 MHz, CDCl3):  = 1.34 (d, 3H, J 6.5 Hz, CH3), 2.12-2.21 (m, 1H, 7Hanti), 
2.56-2.71 (m, 2H, H7syn + H3exo), 3.22 (q, 1H, J 6.5 Hz, CHCH3), 3.15-3.25 (m, 1H, 
H4), 3.72-3.82 (m, 2H, CH2OH), 4.72 (br.s, 1H, D2O exch., OH), 5.05 (d, 1H, J 7.1 Hz, 
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H1), 5.65 (dd, 1H, J 5.6, 2.2 Hz, H5), 5.96 (m, 1H, H6), 7.22-7.33 (m, 5H, Ph). 
13
C 
NMR (CDCl3):  = 24.6 (CH3), 33.0 (C7), 42.0 (C4), 57.4 (C1), 58.7 (CHCH3), 69.4 
(CH2OH), 89.2 (C3), 127.1, 127.5 and 128.8 (CHPh), 130.2 (C5), 136.3 (C6), 146.1 
(C1Ph-CH). IR (NaCl):  = 3310, 3059, 2962, 2851, 1676, 1492, 1450, 1357, 1208, 1134, 
1041, 990, 929, 861, 762, 701 cm
-1
. Anal. calcd. for C15H19NO: C 78.56, H 8.35, N 
6.11; found: C 78.55 H 8.34, N 6.10. 
4.6. General procedure for preparation of 3,5-dinitrobenzoates15a 
4.6.1. (-)-(1S,3S,4R)-2-[(1S)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-en-3-
yl]methyl 3,5-dinitrobenzoate [(-)-8B] from (-)-7B.  
A mixture of alcohol (-)-7B (71 mg, 0.31 mmol), 3,5-dinitrobenzoyl chloride (144 mg, 
0.62 mmol; freshly crystallized from CCl4), DMAP (76.3 mg; 0.62 mmol) in dry DCM 
(10 mL) was stirred under argon for 48 h at rt. The mixture was washed with 0.5 M 
NaOH solution (3 x 60 mL), 0.5 M HCl solution (3 x 80 mL) and brine (80 mL). The 
organic layer was dried (Na2SO4), and removal of the solvent left an yelow oil. Flash 
cromatography of the crude product (Hexane:EtOAc 9:1) afforded a white solid (Rf  0.7; 
1.21 g, 92%) identified as the pure 3,5-dinitrobenzoate  (-)-8B. M.p. 127-130ºC. []D
25
 -
43.47 (c 1, CHCl3). 
1
H NMR (300 MHz, CDCl3):  = 1.32 (d, 1H, J 8.6 Hz, H7anti), 1.36 
(d, 3H, J 6.5 Hz, CH3), 1.72 (d, 1H, J 8.5 Hz, H7syn), 2.25 (dd, 1H, J 10.0, 3.8 Hz, 
H3endo), 2.99 (s, 1H, H4), 3.16 (q, 1H, J 6.5 Hz, CHCH3), 3.44-3.51 (m, 1H, H1), 4.24-
4.31 (t, 1H, J 11.1 Hz, CHHO), 4.86 (dd, 1H, J 11.1, 3.8 Hz, CHHO), 6.07 (dd, 1H, J 
5.6, 1.8 Hz, H6), 6.38 (dd, 1H, J 5.0, 3.4 Hz, H5), 7.23-7.36 (m, 5H, Ph), 9.20 (d, 2H, J 
2.1 Hz, H2ortho + H6ortho), 9.24 (t, 1H, J 2.1 Hz, H4para). 
13
C NMR (CDCl3):  = 25.0 
(CH3), 45.0 (C7), 46.6 (C4), 60.1 (C3), 63.4 (C1), 63.8 (CHCH3), 71.2 (CH2O), 122.8 
(C4Ph), 127.4, 127.7 and 128.9 (CHPh), 129.9 (double) (C2DNP + C6DNP), 134.2 (C5), 
134.4 (C1Ph), 136.0 (C6), 145.7 (C1DNP), 149.1 (C3DNP + C5DNP), 162.9 [C(O)O]. IR 
(KBr):  = 2974, 1723, 1684, 1653, 1629, 1541, 1457, 1343, 1280, 1169, 1136, 1074, 
964, 913, 770, 729, 702 cm
-1
. Anal. calcd. for C22H21N3O6: C 62.41, H 5.00, N 9.92; 
found: C 62.39, H 4.95, N 9.89. Suitable crystals of (-)-(1S,3exo)-8B were obtained 
from hexane/Et2O and the structure was confirmed by the X-ray crystallographic 
analysis.
18 
4.6.2. (+)-(1R,3R,4S)-2-[(1S)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-en-3-
yl]methyl 3,5-dinitrobenzoate [(+)-8A] from (+)-7A. 
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Following the same procedure as above, using the alcohol (+)-7A (80 mg, 0.35 mmol). 
Flash cromatography of the crude product (Hexane:EtOAc 9:1) afforded compound (+)-
8A (Rf  0.7; 135 mg; 91%), as white solid. M.p. 95-98ºC (pentane). []D
25 
+3.02 (c 1, 
CHCl3). 
1
H NMR (300 MHz, CDCl3):  = 1.40 (d, 3H, J 6.5 Hz, CH3), 1.48 (d, 1H, J 
8.4 Hz, 7Hanti), 1.76 (d, 1H, J 8.4 Hz, 7Hsyn), 2.08 (dd, 1H, J 9.6, 4.1 Hz, H3endo), 2.84 
(d, 1H, J 1.2 Hz, H4), 3.11 (q, 1H, J 6.5 Hz, CHCH3), 3.72 (dd, 1H, J 11.0, 4.2 Hz, 
CHHO), 3.92 (dd, 1H, J 11.0, 9.9 Hz, CHHO), 4.24 (d, 1H, J 1.2 Hz, H1), 6.27 (dd, 1H, 
J 5.7, 1.7 Hz, H6), 6.45 (dd, 1H, J 4.8, 3.3 Hz, H5), 7.18-7.35 (m, 5H, Ph), 9.00 (d, 2H, 
J 2.0 Hz, H2ortho + H6ortho), 9.18 (t, 1H, J 4.2 Hz, Jd = 2.0 Hz, H4para). 
13
C NMR 
(CDCl3):  = 22.7 (CH3), 45.0 (C7), 45.9 (C4), 61.8 (C3), 63.5 (C1), 63.8 (CHCH3), 
70.0 (CH2O), 122.6 (C4Ph), 127.8, 128.3 and 128.9 (CHPh), 129.8 (double) (C2DNP + 
C6DNP), 133.0 (C6), 134.4 (C1Ph), 136.6 (C5), 146.1 (C1DNP), 149.0 (double) (C3DNP + 
C5DNP), 162.4 [C(O)O]. IR (KBr):  = 2968, 1726, 1653, 1629, 1547, 1457, 1344, 1284, 
1172, 1072, 968, 919, 756, 720, 704 cm
-1
. Anal. calcd. for C22H21N3O6: C 62.41, H 
5.00, N 9.92; found: C 62.37, H 4.93, N 9.87. 
4.6.3. (-)-(1S,3S,4R)-2-[(1R)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-en-3-
yl]methyl 3,5-dinitrobenzoate [(-)-8A] from (-)-7A.  
Following the same procedure as above, using the alcohol (-)-7A (90 mg, 0.39 mmol). 
Flash cromatography of the crude product (Hexane:EtOAc 9:1) afforded compound (-)-
8A (Rf  0.7; 149 mg; 90%), as white solid. M.p. 95-98ºC (pentane). []D
25 
-3.01 (c 1, 
CHCl3). The NMR (
1
H, 
13
C) spectra are identical to those of compound (+)-8A. Anal. 
calcd. for C22H21N3O6: C 62.41, H 5.00, N 9.92; found: C 62.39, H 4.96, N 9.90. 
4.7. (-)-(1R,2S,5R)-8-phenylmenthyl (1R,3S,4S,5R,6S)-5,6-dihydroxy-2-[(1S)-1-
phenylethyl)]-2-azabicyclo[2.2.1]hept-5-ene-3-carboxylate (-)-9 from (-)-6a. 
A solution of adduct (-)-6a (0.60 g, 1.3 mmol), NMO (0.21 g, 1.01 eq.) and OsO4 (1,5 
mL, 0.0039 M sol. in water, 0.45 mol %) in tert-butanol/THF/water 9:15:1 (7 mL) was 
stirred at ambient temperature under argon for 1 hour. The reaction mixture was then 
filtered through a celite pad and washed with THF. Removal of the solvent on a 
rotavapor yielded a bordeaux residue which was purified by column chromatography 
(silica gel) using hexane: EtOAc 3:2 as eluent. Fractions 3-9 (Rf  0.35) afforded a light 
pink oil (0.50 g) which solidified on standing and which was identified as the 
dihydroxylated adduct (-)-9. Yield 79%. Suitable white crystals of (-)-9 were obtained 
from hexane/EtOAc and the structure was confirmed by X-ray crystallographic 
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analysis.
19 
M.p. 202-204 ºC (hexane). []D
23
 -15.1º (c 1, CHCl3). 
1
H NMR (400 MHz, 
CDCl3):  = 0.91 (d, 3H, J 6.4 Hz, 5’-CH3), 0.92-1.07 (m, 2H, H4’a + H6’a), 1.08-1.19 
(m, 1H, H3’a), 1.21 (d, 3H, J 6.4 Hz, CHCH3Ph), 1.23 (s, 3H, 8’-CH3), 1.27 (d, 1H, J 
10.8 Hz, H7syn), 1.34 (s, 3H, 8’-CH3), 1.45-1.57 (m, 1H, H5’), 1.58 (d, 1H, J 10.8 Hz, 
H7anti), 1.62-1.79 (m, 2H, H4’b + H3’b), 1.99-2.08 (m, 1H, H6’b), 2.09-2.15 (m, 1H, 
H2’), 2.16 (d, 1H, J 2.0 Hz, H4), 2.45 (br s, 1H, exc. D2O, OH), 2.69 (d, 1H, J 4.0 Hz, 
H3exo), 2.76 (br s, 1H, exc. D2O, OH), 2.82 (br s, 1H, H1), 3.46 (q, 1H, J 6.4 Hz, 
CHCH3Ph), 3.68 (br s, 1H, H5), 3.84 (br s, 1H, H6), 4.74 (dt, 1H, Jt 10.8 Hz, Jd 6.4 Hz, 
H1’), 7.15-7.43 (m, 10H, Ph). 13C NMR (CDCl3):  = 21.8 (5’-CH3), 22.5 (CH3CHPh), 
24.9 (8’-CH3), 26.5 (C3’), 28.0 (8’-CH3), 29.0 (C7), 31.3 (C5’), 34.6 (C4’), 39.6 (C8’), 
41.29 (C6’), 47.6 (C4), 50.1 (C2’), 63.2 (CHPh), 64.0 (C1), 65.0 (C3), 69.9 (C5), 73.3 
(C6), 75.3 (C1’), 124.9, 125.3, 127.0, 127.2, 127.9 and 128.4 (CHPh), 145.8 (C1Ph-C8’), 
152.0 (C1Ph-CH), 172.0 [C(O)O]. IR (neat): 3435, 2952, 1725, 1493, 1454, 1373, 1134, 
1074, 1026, 980, 910, 842, 781, 764, 729 cm
-1
. Anal. calcd. for C31H41NO4: C 75.73, H 
8.41, N 2.85; found: C 75.81, H 8.50, N 2.78. 
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